Using Untargeted Metabolomics to Identify Urinary Biomarkers of Onion Intake
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Elliot Owen, MSc
- Phone Number: 07515694340
- Email: elliot.owen@MMU.AC.uk
Study Locations
-
-
-
Manchester, United Kingdom
- Manchester Metropolitan University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy
- Non-pregnant/lactating
- BMI between 18.5 and 30 kg/m^2
- Non-smokers.
Exclusion Criteria:
- Any diagnosed health condition (chronic or infectious diseases)
- Consumption of medications/nutritional supplements
- Any allergies/intolerances to onions/couscous.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Onion feeding first, couscous feeding second
Participants will report to the laboratory at 8am in a fasted state (water consumption is permitted) and provide a spot baseline urine sample.
Participants will then be served a 120g portion of onions (experimental condition), prepared under standardized conditions.
Participants shall remain supervised in the laboratory and will only consume water (100mL per hour) for the subsequent 6 hours, after which participants are free to consume their habitual diet (except alcohol, tea coffee, and FVs).
In the 24-hour postprandial test period, participants will obtain urine samples at several time-points.
Urine collection vessels will be used to obtain samples at 0-1, 1-2, 2-4, 4-6, 6-12, 12-24 hours.
This experimental protocol shall be repeated following a 4-day washout period (habitual diet consumption with no restrictions imposed on participants) with 120g of couscous consumed instead of onions, as a control condition.
|
The intervention includes feeding individuals a 120g portion of onions (experimental condition).
The intervention includes feeding individuals a 120g portion of couscous (control condition).
|
|
Experimental: Couscous feeding first, onion feeding second
Participants will report to the laboratory at 8am in a fasted state (water consumption is permitted) and provide a spot baseline urine sample.
Participants will then be served a 120g portion of couscous (control condition), prepared under standardized conditions.
Participants shall remain supervised in the laboratory and will only consume water (100mL per hour) for the subsequent 6 hours, after which participants are free to consume their habitual diet (except alcohol, tea coffee, and FVs).
In the 24-hour postprandial test period, participants will obtain urine samples at several time-points.
Urine collection vessels will be used to obtain samples at 0-1, 1-2, 2-4, 4-6, 6-12, 12-24 hours.
This experimental protocol shall be repeated following a 4-day washout period (habitual diet consumption with no restrictions imposed on participants) with 120g of onions consumed instead of couscous, as an experimental condition.
|
The intervention includes feeding individuals a 120g portion of onions (experimental condition).
The intervention includes feeding individuals a 120g portion of couscous (control condition).
|
|
Other: Onion supplementation period
This dose-dependent biomarker validation intervention will include three 4-day supplementation periods separated by two 3-day washout periods.
Supplementation periods will provide participants with a daily portion of onions to be consumed with their evening meals.
The daily quantity of onion supplementation, low (40g), medium, (80g) and high (160g), will remain constant throughout each 4-day period, and the order will be individually randomised.
Participants will be asked to avoid onion intake throughout the supplementation periods, other than the portions provided by researchers.
First morning void urine samples will be collected by participants on the morning after the supplementation period and obtained by researchers.
|
Three 4-day supplementation periods separated by two 3-day washout periods.
Supplementation periods will provide participants with a daily portion of onions to be consumed with their evening meals.
The daily quantity of onion supplementation, low (40g), medium, (80g) and high (160g), will remain constant throughout each 4-day period, and the order will be individually randomised.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Untargeted metabolomics for onion biomarker identification using LC-QTOF-MS.
Time Frame: 24-hours postprandial period following onion or couscous consumption.
|
Urine samples will be analysed to putatively identify biomarkers of onion intake by comparison with control samples using high-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer (LC-QTOF-MS).
LC-QTOF-MS analysis allows the simultaneous high-resolution measurement of a broad range of metabolites, hence the untargeted nature of the analysis.
Multivariate statistical analysis and Partial least squares Discriminant Analysis included in the mass spectrometry software will be used to analyse LC-QTOF-MS results to identify features that best discriminate between test and control conditions.
|
24-hours postprandial period following onion or couscous consumption.
|
|
Dose-dependency and change in concentration of potential biomarkers identified in Primary Outcome 1
Time Frame: First morning void urine samples following three periods of 4-day onion supplementation.
|
First morning void urine samples will be obtained after three separate 4-day periods of supplementing evening meals with 40g, 80g and 160g of onions.
The validity of candidate biomarkers from the first phase of the study, Primary Outcome 1, shall be assessed by LC-QTOF-MS - quantifying urinary concentrations following the consumption of multiple doses of onions across a range of servings.
|
First morning void urine samples following three periods of 4-day onion supplementation.
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 34047
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.